pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
PBXCT-02
Bladder Cancer
Celltrion Inc
0
catalysts
Phase 1
PCNAT-01
Pancreatic Ductal Adenocarcinoma
Anda Biopharmaceutical Development (Shenzhen) Co Ltd
0
catalysts
Preclinical
PCS-11T
Metastatic Colorectal Cancer
$PCSA
Processa Pharmaceuticals, Inc.
0
catalysts
Phase 3
← prev
page 30 of 62
next →
131
Pain
89
Neurology
1
PD-L1 t-haNK
Metastatic Pancreatic Cancer
$IBRX
ImmunityBio, Inc.
0
catalysts
Phase 3
PDS-0101
Hypopharyngeal Cancer
$PDSB
PDS Biotechnology Corp
0
catalysts
Phase 2
PEEL-224
Neuroblastoma
Peel Therapeutics Inc
0
catalysts
Phase 1
PF-08046052
Head And Neck Squamous Cell Carcinoma (HNSC)
$PFE
PFIZER INC
0
catalysts
Phase 1
PF-08052666
Endometrial Cancer
$PFE
PFIZER INC
0
catalysts
Phase 2
PFL-002
Non-Small Cell Lung Cancer
Pierre Fabre Pharmaceuticals Inc
0
catalysts
Phase 2
PFL-241
Non-Small Cell Lung Cancer
Laboratoires Pierre Fabre SA
0
catalysts
Phase 2
PFL-721
Non-Small Cell Lung Cancer
Laboratoires Pierre Fabre SA
0
catalysts
Phase 1
PH-762
Cutaneous Squamous Cell Carcinoma (cSCC)
$PHIO
Phio Pharmaceuticals Corp.
0
catalysts
Phase 1
PHST-001
Ovarian Cancer
Pheast Therapeutics Inc
0
catalysts
Phase 1
PIN-5018
Adenoid Cystic Carcinoma (ACC)
Pin Therapeutics Inc
0
catalysts
Preclinical
PJ-34
Pancreatic Cancer
Tel Aviv University
0
catalysts
Preclinical
PKC Delta Inhibitors
Unspecified Cancer
Phoenicia Biosciences Inc
0
catalysts
Phase 1
PLN-101095
Anal Cancer
$PLRX
PLIANT THERAPEUTICS, INC.
0
catalysts
Phase 1
PLT-012
Hepatocellular Carcinoma
Pilatus Biosciences SA
0
catalysts
Phase 1
PM-54
Adrenocortical Carcinoma (Adrenal Cortex Cancer)
Pharma Mar SA
0
catalysts
Phase 1
PMBCT-01
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
PeproMene Bio Inc
0
catalysts
Phase 2
PMD-026
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Phoenix Molecular Designs
0
catalysts
Phase 1
PQ-203
Triple-Negative Breast Cancer (TNBC)
ProteinQure Inc
0
catalysts
Phase 2
PR-001
Parkinson's Disease
Prevail Therapeutics Inc
0
catalysts
Preclinical
PRF-140 SR
Unspecified Cancer
$PRFX
PRF Technologies Ltd.
0
catalysts
Phase 2
PRGN-2009
Anal Cancer
$PGEN
PRECIGEN, INC.
0
catalysts
Phase 1
PRGN-3006
Myelodysplastic Syndrome (Preleukemia)
$PGEN
PRECIGEN, INC.
0
catalysts
Phase 2
PRL3-ZUMAB
Solid Tumor
IISG Pte Ltd
0
catalysts
Preclinical
PRST-33
Prostate Cancer
$CNBX
CNBX Pharmaceuticals Inc.
0
catalysts
Phase 1
PRT-12396
Myelofibrosis
$PRLD
Prelude Therapeutics Inc
0
catalysts
Preclinical
PRV-311
Cervical Cancer
Privo Technologies Inc
0
catalysts
